NYSE:ISR

Isoray (ISR) Stock Forecast, Price & News

Today's Range: N/A
50-Day Range: $0.28
▼
$0.42
52-Week Range: N/A

Volume: 145,000 shs
Average Volume: 290,697 shs
Market Capitalization: $54.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Isoray (NYSE:ISR) Stock

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Stock News Headlines

June 2, 2023 | americanbankingnews.com

Isoray (NYSE:ISR) Now Covered by Analysts at StockNews.com

May 26, 2023 | americanbankingnews.com

Isoray (NYSE:ISR) Research Coverage Started at StockNews.com

June 9, 2023 | UNKNOWN (Ad)

This Company Is Solving A Multi-Billion Dollar Problem!

This Little Known NASDAQ Stock is Solving a Multi-Billion Dollar Problem!

May 10, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on Isoray (NYSE:ISR)

April 24, 2023 | thestreet.com

Why IsoRay (ISR) Is Plunging Today

April 23, 2023 | americanbankingnews.com

Isoray (NYSE:ISR) Receives New Coverage from Analysts at StockNews.com

April 17, 2023 | americanbankingnews.com

Head to Head Contrast: Quipt Home Medical (NASDAQ:QIPT) and Isoray (NYSE:ISR)

April 16, 2023 | americanbankingnews.com

Isoray (NYSE:ISR) Now Covered by StockNews.com

June 9, 2023 | Behind the Markets (Ad)

[BREAKING] Pentagon to Spend Billions on "Living Missile"

Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!

April 8, 2023 | americanbankingnews.com

Isoray (NYSE:ISR) Coverage Initiated at StockNews.com

March 25, 2023 | americanbankingnews.com

Comparing Paragon 28 (NYSE:FNA) and Isoray (NYSE:ISR)

March 16, 2023 | thestreet.com

Why IsoRay (ISR) Stock Is Surging Today

February 16, 2023 | finance.yahoo.com

IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates

February 16, 2023 | finance.yahoo.com

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022

February 8, 2023 | finanznachrichten.de

Isoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

February 7, 2023 | finance.yahoo.com

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

February 6, 2023 | finance.yahoo.com

Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine

January 30, 2023 | benzinga.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 30, 2023 | finance.yahoo.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 14, 2023 | thestreet.com

Why IsoRay (ISR) Hit a Five-Year High Today (Update)

January 12, 2023 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023

December 14, 2022 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022

December 14, 2022 | finance.yahoo.com

AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

December 6, 2022 | proactiveinvestors.com

Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023

December 6, 2022 | proactiveinvestors.com

Isoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular Targeting

November 25, 2022 | finance.yahoo.com

Isoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo Finance

November 11, 2022 | finanznachrichten.de

Isoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

See More Headlines

ISR Company Calendar

Last Earnings: 11/10/2021
Today: 6/09/2023
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:ISR
CUSIP: N/A
CIK: 728387
Web: isoray.com
Phone: (509) 375-1202
Fax: 509-267-3670
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,270,000.00
Net Margins: -115.91%
Pretax Margin: -91.45%
Return on Equity: -17.12%
Return on Assets: -16.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 14.38
Quick Ratio: 13.99

Sales & Book Value

Annual Sales: $10.80 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.43 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 142,110,000
Free Float: 138,674,000
Market Cap: $54.57 million
Optionable: Not Optionable
Beta: 1.48

Key Executives

Lori A. Woods
Chief Executive Officer & Director

Jennifer Streeter
Chief Operating Officer & VP-Human Resources

Mark J. Austin
Co-CFO, Secretary & Chief Accounting Officer

Jonathan R. Hunt
CFO & Principal Financial Officer

William A. Cavanagh
Chief Research & Development Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ISR Stock - Frequently Asked Questions

How were Isoray's earnings last quarter?: Isoray, Inc. (NYSE:ISR) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm had revenue of $2.56 million for the quarter, compared to the consensus estimate of $2.58 million. Isoray had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 17.12%.
What is Isoray's stock symbol?: Isoray trades on the New York Stock Exchange (NYSE) under the ticker symbol "ISR."

How do I buy shares of Isoray?: Shares of ISR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How much money does Isoray make?: Isoray (NYSE:ISR) has a market capitalization of $0.00 and generates $10.80 million in revenue each year. The company earns $-7,270,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis.
How can I contact Isoray?: Isoray's mailing address is 350 HILLS STREET SUITE 106, RICHLAND WA, 99354. The official website for the company is isoray.com. The company can be reached via phone at (509) 375-1202, via email at dbabcock@isoray.com, or via fax at 509-267-3670.

This page (NYSE:ISR) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial